Literature DB >> 15187157

Basophils infiltrate human gastric mucosa at sites of Helicobacter pylori infection, and exhibit chemotaxis in response to H. pylori-derived peptide Hp(2-20).

Amato de Paulis1, Nella Prevete, Isabella Fiorentino, Andrew F Walls, Monica Curto, Angelica Petraroli, Vincenza Castaldo, Paola Ceppa, Roberto Fiocca, Gianni Marone.   

Abstract

Basophils, which are normally confined to the circulation, can migrate to sites of allergic inflammation. Using the specific mAb, BB1, we detected basophil infiltration of the gastric mucosa of Helicobacter pylori-infected patients affected by moderate and severe gastritis. Basophils were not found in H. pylori-free individuals or in subjects with mild gastritis. The H. pylori-derived peptide, Hp(2-20), was a potent basophil chemoattractant in vitro, whereas the control peptide, Hp1, was ineffective. Basophils from peripheral blood of healthy volunteers expressed mRNA for the formyl peptide receptors, N-formyl-peptide receptor (FPR), FPR-like (FPRL)1, and FPRL2. Preincubation of basophils with FMLP or Hp(2-20) caused complete desensitization to a subsequent challenge with homologous stimulus. Incubation of basophils with a low concentration of FMLP, which binds with high affinity to FPR, but not to FPRL1 or FPRL2, did not affect the chemotactic response to Hp(2-20). In contrast, a high concentration of FMLP, which binds to FPRL1 and FPRL2, reduced the chemotactic response to Hp(2-20). The FPR antagonist, cyclosporin H, prevented chemotaxis induced by FMLP, but not by Hp(2-20). Hp(2-20) could be responsible, at least in part, for basophil infiltration of the gastric mucosa of H. pylori-infected patients presumably through the interaction with FPRL1 and FPRL2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187157     DOI: 10.4049/jimmunol.172.12.7734

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  A bactericidal cecropin-A peptide with a stabilized alpha-helical structure possess an increased killing capacity but no proinflammatory activity.

Authors:  Huamei Fu; Ase Björstad; Claes Dahlgren; Johan Bylund
Journal:  Inflammation       Date:  2004-12       Impact factor: 4.092

Review 2.  Basophils and type 2 immunity.

Authors:  Booki Min; William E Paul
Journal:  Curr Opin Hematol       Date:  2008-01       Impact factor: 3.284

3.  The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.

Authors:  N Prevete; F Liotti; C Visciano; G Marone; R M Melillo; A de Paulis
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

Review 4.  Enemy attraction: bacterial agonists for leukocyte chemotaxis receptors.

Authors:  Dominik Alexander Bloes; Dorothee Kretschmer; Andreas Peschel
Journal:  Nat Rev Microbiol       Date:  2014-12-15       Impact factor: 60.633

5.  Mitochondrial N-formyl peptides induce cardiovascular collapse and sepsis-like syndrome.

Authors:  Camilla Ferreira Wenceslau; Cameron G McCarthy; Theodora Szasz; Styliani Goulopoulou; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-01-30       Impact factor: 4.733

6.  IL-3 synergises with basophil-derived IL-4 and IL-13 to promote the alternative activation of human monocytes.

Authors:  Francesco Borriello; Michele Longo; Rosa Spinelli; Antonio Pecoraro; Francescopaolo Granata; Rosaria Ilaria Staiano; Stefania Loffredo; Giuseppe Spadaro; Francesco Beguinot; John Schroeder; Gianni Marone
Journal:  Eur J Immunol       Date:  2015-04-28       Impact factor: 5.532

Review 7.  Basophils, IgE, and autoantibody-mediated kidney disease.

Authors:  Xavier Bosch; Francisco Lozano; Ricard Cervera; Manuel Ramos-Casals; Booki Min
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

8.  Increases in Nonspecific Immunoglobulin E and Eosinophils after H. pylori Eradication.

Authors:  Yoshihiro Matsukawa; Yasuhiro Gon; Akihiro Hemmi; Jin Takeuchi; Shigemasa Sawada; Izumi Hayashi
Journal:  Case Rep Gastroenterol       Date:  2010-02-03

Review 9.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

10.  Peptide Hp(2-20) accelerates healing of TNBS-induced colitis in the rat.

Authors:  A G Gravina; N Prevete; C Tuccillo; C De Musis; L Romano; A Federico; A de Paulis; G D'Argenio; M Romano
Journal:  United European Gastroenterol J       Date:  2018-08-24       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.